keyword
Keywords Melanoma clinical pathological...

Melanoma clinical pathological correlation

https://read.qxmd.com/read/38520953/b7-h3-is-associated-with-the-armored-cold-phenotype-and-predicts-poor-immune-checkpoint-blockade-response-in-melanoma
#1
JOURNAL ARTICLE
Bozhi Shen, Jie Mei, Rui Xu, Yun Cai, Mengyun Wan, Ji Zhou, Junli Ding, Yichao Zhu
Melanoma is the most suitable tumor type for immunotherapy, but not all melanoma patients could respond to immunotherapy. B7 homolog 3 (B7-H3) belongs to the B7 family and is overexpressed in a number of malignant tumors, but the expression pattern of B7-H3 in melanoma has not been well summarized. The expression of B7-H3 was investigated in melanoma and its correlations with features of the tumor microenvironment (TME) by using various public databases, including the Cancer Genome Atlas (TCGA), the GEPIA, and the Human Protein Atlas databases...
March 18, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38513115/onychocytic-matricoma-a-clinical-dermoscopic-and-pathological-analysis-of-14-cases
#2
JOURNAL ARTICLE
Christophe Perrin, Michael Coutts, Feriel Boukari, Damien Ambrosetti
Onychocytic matricoma (OCM) is a benign neoplasm of the nail matrix. Only 18 cases of this tumor have been reported in the literature to date. We retrospectively analyzed the clinical features of 14 patients with OCM. The most common clinical feature was longitudinal xanthopachyonychia (n = 9), followed by longitudinal leukopachyonychia (=3) and longitudinal pachymelanonychia (n = 2). The most common clinical findings identified following dermoscopy and analysis at high magnification of classical photographs were free-edge thickening of the nail plate without pitting (n = 14), longitudinal ridging (n = 7), round white clods (n = 7), white dots (n = 7), and filiform hemorrhages (n = 7), followed by oval and linear white clods (n = 5), fuzzy lateral border (n = 5), and red-purple blood clods (n = 3)...
March 19, 2024: American Journal of Dermatopathology
https://read.qxmd.com/read/38491443/thickness-of-melanocytes-in-giant-congenital-melanocytic-nevus-for-complete-surgical-excision-clinicopathological-evaluation-of-117-lesions-according-to-the-area-and-size
#3
JOURNAL ARTICLE
Ji-Young Kim, Se Yeon Lee, Yoonjin Kwak, Byung Jun Kim
BACKGROUND: Giant congenital melanocytic nevi (GCMN) are usually defined as nevi that exceed 20 cm in maximal diameter or 15% of the total body surface area. There have been reports of life-long malignant change risks arising from GCMN, leading to surgical excision of GCMN. This study aims to evaluate the thickness of melanocytes based on clinical factors in order to provide objective information for the complete resection of the lesion. METHODS: Overall, 75 patients diagnosed with GCMN between 2000 and 2021 were included, and their clinical records were collected retrospectively...
March 15, 2024: BMC Surgery
https://read.qxmd.com/read/38486392/comprehensive-pan-cancer-analysis-of-cmpk2-as-biomarker-and-prognostic-indicator-for-immunotherapy
#4
JOURNAL ARTICLE
Jingyuan Luo, Qianyue Zhang, Shutong Wang, Luojie Zheng, Jie Liu, Yuchen Zhang, Yingchen Wang, Ranran Wang, Zhigang Xiao, Zheng Li
INTRODUCTION: UMP-CMP kinase 2 (CMPK2) is involved in mitochondrial DNA synthesis which can be oxidized and released into the cytoplasm in innate immunity. It initiates the assembly of NLRP3 inflammasomes and mediates various pathological processes such as human immunodeficiency virus infection and systemic lupus erythematosus. However the role of CMPK2 in tumor progression and tumor immunity remains unclear. METHOD: In this study we conducted a systematical analysis of CMPK2 across 33 different cancers based on datasets such as Genotype Tissue-Expression (GTEx) The Cancer Genome Atlas (TCGA) the Cancer Cell Line Encyclopedia (CCLE) and Tumor Immune Syngeneic Mouse (TISMO)...
March 13, 2024: Current Cancer Drug Targets
https://read.qxmd.com/read/38416928/a-spectrum-of-metastases-to-the-breast-radiologic-pathologic-correlation
#5
JOURNAL ARTICLE
Jorge L Huayanay Espinoza, Fiorela N Mego Ramírez, Henry Guerra Miller, Jorge L Huayanay Santos, Mark Guelfguat
Metastases to the breast from non-mammary origin are rare. The majority of these lesions appear as secondary manifestations of melanoma and lymphoma, followed by lung carcinomas, gynecological carcinomas, and sarcomas. There has been a steady trend of an increase in diagnosis of intramammary metastases owing to the current advances in imaging technology. Imaging features depend on the type of primary neoplasm and route of dissemination, some of which resemble primary breast cancer and benign breast entities...
March 20, 2023: Journal of breast imaging
https://read.qxmd.com/read/38391320/angiosarcoma-of-the-head-and-neck-a-clinicopathologic-study-with-special-emphasis-on-diagnostic-pitfalls
#6
JOURNAL ARTICLE
Jayapriya Gangadharan, Anitha Mathews, Sindhu N Prasanna Kumary, Thara Somanathan, K Jayasree, Geetha Narayanan
BACKGROUND AND AIMS: Angiosarcoma (AS) is a rare malignant vascular tumor that phenotypically and functionally recapitulate normal endothelium. They constitute approximately 2-4% of soft tissue sarcomas. We present 36 cases of head and neck AS diagnosed for 11 years at a tertiary care hospital in South India to analyze the clinical, pathological, and immunophenotypic profiles with special emphasis on their differential diagnoses and diagnostic pitfalls. MATERIALS AND METHODS: Head and neck AS diagnosed from January 2006 to December 2017 were included...
February 14, 2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38378246/the-difficulty-with-measuring-the-largest-melanoma-tumour-diameter-in-sentinel-lymph-nodes
#7
JOURNAL ARTICLE
Annelien E Laeijendecker, Mary-Ann El Sharouni, Nikolaos Stathonikos, Clothaire P E Spoto, Bart A van de Wiel, Erik J E Eijken, Marijne Mulder, Antien L Mooyaart, Anna Szumera-Cieckiewicz, Daniela Mihic-Probst, Daniela Massi, Martin Cook, Senada Koljenovic, Llucia Alos, Paul J van Diest, Alexander C J van Akkooi, Willeke Blokx
Identification of sentinel node (SN) metastases can set the adjuvant systemic therapy indication for stage III melanoma patients. For stage IIIA patients, a 1.0 mm threshold for the largest SN tumour diameter is used. Therefore, uniform reproducible measurement of its size is crucial. At present, the number of deposits or their microanatomical sites are not part of the inclusion criteria for adjuvant treatment. The goal of the current study was to show examples of the difficulty of measuring SN melanoma tumour diameter and teach how it should be measured...
February 20, 2024: Journal of Clinical Pathology
https://read.qxmd.com/read/38348498/clinical-and-genetic-determinants-of-vitamin-d-receptor-expression-in-cutaneous-melanoma-patients
#8
JOURNAL ARTICLE
Julie De Smedt, Claudia Aura, Sofie Van Kelst, Laudine Janssen, Vivien Marasigan, Veerle Boecxstaens, Marguerite Stas, Kris Bogaerts, Ann Belmans, Isabelle Cleynen, Dirk Vanderschueren, Katleen Vandenberghe, Oliver Bechter, Arjen Nikkels, Tinne Strobbe, Gabriella Emri, Dieter Lambrechts, Marjan Garmyn
Decrease of vitamin D receptor (VDR) expression is observed in melanocytic naevi and melanoma compared to normal skin. Little is known about factors influencing VDR expression in cutaneous melanoma (CM). We investigated the correlation of VDR expression in CM with 25-hydroxy vitamin D (25OHD) levels, demographic/clinical parameters, genetic variants of VDR and pathology of the primary tumor. Demographic/clinical parameters were recorded in 407 prospectively recruited CM patients of a multi-center controlled study (ViDMe trial)...
February 13, 2024: Melanoma Research
https://read.qxmd.com/read/38337588/diagnostic-imaging-of-agminated-blue-lesions-and-blue-lesions-with-satellitosis-case-series-with-a-concise-review-of-the-current-literature
#9
JOURNAL ARTICLE
Carmen Cantisani, Giovanni Paolino, Antonio Di Guardo, Vito Gomes, Andrea Carugno, Maria Elisabetta Greco, Noah Musolff, Giulia Azzella, Giovanni Rossi, Giuseppe Soda, Caterina Longo, Giovanni Pellacani
Background: Agmination and/or satellitosis in pigmented blue lesions is a phenomenon rarely mentioned in the literature and not well known. This phenomenon can be expressed by several benign and malignant pigmented blue lesions, such as blue nevi, Spitz nevi, melanocytoma and melanoma. On this spectrum, dermoscopy, reflectance confocal microscopy (RCM) and dynamic Optical coherence tomography (D-OCT) represent non-invasive imaging technologies, which may help clinicians in the diagnosis of melanoma and non-melanoma skin cancers in daily clinical practice...
February 3, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38326303/androgen-drives-melanoma-invasiveness-and-metastatic-spread-by-inducing-tumorigenic-fucosylation
#10
JOURNAL ARTICLE
Qian Liu, Emma Adhikari, Daniel K Lester, Bin Fang, Joseph O Johnson, Yijun Tian, Andrea T Mockabee-Macias, Victoria Izumi, Kelly M Guzman, Michael G White, John M Koomen, Jennifer A Wargo, Jane L Messina, Jianfei Qi, Eric K Lau
Melanoma incidence and mortality rates are historically higher for men than women. Although emerging studies have highlighted tumorigenic roles for the male sex hormone androgen and its receptor (AR) in melanoma, cellular and molecular mechanisms underlying these sex-associated discrepancies are poorly defined. Here, we delineate a previously undisclosed mechanism by which androgen-activated AR transcriptionally upregulates fucosyltransferase 4 (FUT4) expression, which drives melanoma invasiveness by interfering with adherens junctions (AJs)...
February 7, 2024: Nature Communications
https://read.qxmd.com/read/38320889/-clinical-histological-and-genetic-correlations-in-melanocytic-tumours-with-chromosomal-rearrangements
#11
JOURNAL ARTICLE
Jeremy Schoelinck, Daniel Pissaloux, Maxime Mouthon, Rémi Vergara, Arnaud de la Fouchardière
In some tumoral subtypes chromosomal translocations lead to an oncogenic chimeric protein acting as a tumorigenesis driver event. The main fusion model combines the promoter swapping of an inactivated tumor suppressor gene and a functional kinase that evades its regulatory system. The range of described fusions keeps growing in the 2023 WHO classification of melanocytic tumours. It is not limited to the group of Spitz tumours as previously but now extends to blue tumours and dermal tumours with a melanocytic phenotype...
February 5, 2024: Annales de Pathologie
https://read.qxmd.com/read/38287901/chemokine-profiling-of-melanoma-macrophage-crosstalk-identifies-ccl8-and-ccl15-as-prognostic-factors-in-cutaneous-melanoma
#12
JOURNAL ARTICLE
Celia Barrio-Alonso, Alicia Nieto-Valle, Elena García-Martínez, Alba Gutiérrez-Seijo, Verónica Parra-Blanco, Iván Márquez-Rodas, José Antonio Avilés-Izquierdo, Paloma Sánchez-Mateos, Rafael Samaniego
During cancer evolution, tumor cells attract and dynamically interact with monocytes/macrophages. To find biomarkers of disease progression in human melanoma, we used unbiased RNA sequencing and secretome analyses of tumor-macrophage co-cultures. Pathway analysis of genes differentially modulated in human macrophages exposed to melanoma cells revealed a general upregulation of inflammatory hallmark gene sets, particularly chemokines. A selective group of chemokines, including CCL8, CCL15, and CCL20, was actively secreted upon melanoma-macrophage co-culture...
January 30, 2024: Journal of Pathology
https://read.qxmd.com/read/38286055/kif4a-functions-as-a-diagnostic-and-prognostic-biomarker-and-regulates-tumor-immune-microenvironment-in-skin-cutaneous-melanoma
#13
JOURNAL ARTICLE
Siyi Zeng, Qirui Wang, Renpeng Zhou, Danru Wang
BACKGROUND: KIF4A is upregulated in various malignancies and serves as an independent risk factor. However, its function in skin cutaneous melanoma (SKCM) and the regulation of the immunological environment remains unknown. METHODS: We first explored the mRNA and protein levels of KIF4A in SKCM through public databases. Then, the co-expressed genes with KIF4A in SKCM and their functional enrichment analysis were performed. Moreover, the clinical value, relationship with immune infiltration and tumor microenvironment (TME), as well as the correlation between KIF4A and immunomodulators were evaluated...
January 24, 2024: Pathology, Research and Practice
https://read.qxmd.com/read/38238977/prognostic-value-of-bap1-protein-expression-in-uveal-melanoma
#14
JOURNAL ARTICLE
Susan Kennedy, Sally Owens, Laura Ivers, Ciara Hegarty, Valerie O'Neill, Jose J Berenguer-Pina, Noel Horgan, John Crown, Naomi Walsh
The prognostic value of the traditional pathologic parameters that form part of the American Joint Committee on Cancer staging system and genetic classifications using monosomy chromosome 3 and structural alterations in chromosome 8 are well established and are part of the diagnostic workup of uveal melanoma (UM). However, it has not been fully clarified whether nuclear protein expression of the tumor suppressor gene BAP1 (nBAP1) by immunohistochemistry alone is as powerful a predictor of overall survival (OS) and/or disease-specific survival (DSS) as chromosome analysis...
March 1, 2024: American Journal of Surgical Pathology
https://read.qxmd.com/read/38224076/clinical-and-histological-response-to-talimogene-laherparepvec-therapy-in-advanced-melanoma-impact-on-overall-survival
#15
JOURNAL ARTICLE
Gabriel O Ologun, C Paige Jones, Kelsey R Landrum, P Veronica Pham, Sherin Ismail, Patricia K Long, Jonathan D Sorah, Karyn B Stitzenberg, Michael O Meyers, David W Ollila
BACKGROUND: Talimogene Laherparepvec (T-VEC) is an FDA-approved oncolytic herpes virus therapy used for unresectable stage IIIB through IV metastatic melanoma. However, the correlation between clinical complete response (cCR) and pathologic complete response (pCR) in T-VEC-treated patients is understudied. STUDY DESIGN: We conducted a retrospective study from a prospectively maintained IRB-approved melanoma single center database in patients treated with T-VEC from October 2015 to April 2022...
January 15, 2024: Journal of the American College of Surgeons
https://read.qxmd.com/read/38201554/prognostic-value-of-baseline-18-f-fdg-pet-ct-to-predict-brain-metastasis-development-in-melanoma-patients
#16
JOURNAL ARTICLE
Forough Kalantari, Seyed Ali Mirshahvalad, Magdalena Hoellwerth, Gregor Schweighofer-Zwink, Ursula Huber-Schönauer, Wolfgang Hitzl, Gundula Rendl, Peter Koelblinger, Christian Pirich, Mohsen Beheshti
To investigate the value of 18 F-FDG-PET/CT in predicting the occurrence of brain metastases in melanoma patients, in this retrospective study 201 consecutive patients with pathology-proven melanoma, between 2008 and 2021, were reviewed. Those who underwent 18 F-FDG-PET/CT for initial staging were considered eligible. Baseline assessment included histopathology, 18 F-FDG-PET/CT, and brain MRI. Also, all patients had serial follow-ups for diagnosing brain metastasis development. Baseline 18 F-FDG-PET/CT parameters were analysed using competing risk regression models to analyze their correlation with the occurrence of brain metastases...
December 26, 2023: Cancers
https://read.qxmd.com/read/38183457/low-incidence-of-braf-and-nras-mutations-in-a-population-with-a-high-incidence-of-melanoma
#17
JOURNAL ARTICLE
Grace Neville, Barbara Marzario, David Shilling, Collette K Hand, Cynthia Heffron
Reported rates of BRAF mutation in Irish cutaneous melanoma cohorts are lower than the reported international data. We aimed to assess the mutational status of a cohort of primary cutaneous melanomas and to correlate it with clinical follow-up data.A total of 92 cases of primary cutaneous melanoma diagnosed at a single institution in 2012 were analyzed. Regions containing common mutations in the BRAF, NRAS, KIT, and KRAS genes were investigated by PCR amplification followed by Sanger sequencing. Demographic details, tumor characteristics, and 10-year outcome data were also obtained...
January 6, 2024: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/38166492/the-role-of-cstf2-in-cancer-from-technology-to-clinical-application
#18
REVIEW
Jiaxiang Ding, Yue Su, Youru Liu, Yuanyuan Xu, Dashuai Yang, Xuefeng Wang, Shuli Hao, Huan Zhou, Hongtao Li
A protein called cleavage-stimulating factor subunit 2 (CSTF2, additionally called CSTF-64) binds RNA and is needed for the cleavage and polyadenylation of mRNA. CSTF2 is an important component subunit of the cleavage stimulating factor (CSTF), which is located on the X chromosome and encodes 557 amino acids. There is compelling evidence linking elevated CSTF2 expression to the pathological advancement of cancer and on its impact on the clinical aspects of the disease. The progression of cancers, including hepatocellular carcinoma, melanoma, prostate cancer, breast cancer, and pancreatic cancer, is correlated with the upregulation of CSTF2 expression...
January 2, 2024: Cell Cycle
https://read.qxmd.com/read/38031947/melanocytic-tumors-with-spitzoid-morphology-correlation-of-clinicopathologic-features-and-fish-analysis
#19
JOURNAL ARTICLE
Deniz Ünlüer Kapişkay, Övgü Aydin Ülgen, Ümit İnce, Cüyan Demirkesen
BACKGROUND: A subset of melanocytic tumors with spitzoid morphology may lead to potential inaccurate diagnosis and lack of assessment of malignancy potential. In this study, we aimed to evaluate melanocytic tumors with spitzoid morphology using conventional melanoma FISH (RREB-1, CCND1, MYB and CEP6) and 9p21 FISH (CDKN2A) probes and compare the probe results with clinical and histopathological features. METHODS: This study is a multicentric retrospective study including three centers, İstanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Department of Pathology, Acıbadem University, School of Medicine, Department of Pathology and ETA Pathology Laboratory...
August 2023: Turkish Journal of Medical Sciences
https://read.qxmd.com/read/38006370/folliculotropism-in-actinic-keratoses-in-patients-not-responding-to-treatments-a-pilot-study
#20
JOURNAL ARTICLE
Emi Dika, Emi Dika, Martina Lambertini, Emi Dika, Martina Lambertini, Giulia Veronesi, Cosimo Misciali, Massimo Milani, Aleksandra Bergant-Suhodolcan, Bor Hrvatin Stancic, Carlotta Baraldi
Dear Editor, Actinic keratoses (AK) have a high prevalence in the general population, with greater rates in Caucasian patients after the fourth and fifth decades of life (37.5-60.0%) (1,2). Standard histopathologic reporting of AKs does not provide information on the presence of atypical keratinocytes extending to the hair follicle, also defined as folliculotropism (FLC). Commonly, atypical cells in AKs do not present FLC, but this feature can be observed in bowenoid AKs with full-thickness epidermal atypia (3,4)...
November 2023: Acta Dermatovenerologica Croatica: ADC
keyword
keyword
169081
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.